# REDEMPLO
> **NDA219947** · New Drug Application · Sponsor: ARROWHEAD · Approved 2025-11-18
## Drug
- **FDA Application Number:** NDA219947
- **Application type:** New Drug Application
- **Brand name:** REDEMPLO
- **Generic name:** PLOZASIRAN
- **Active ingredients:** PLOZASIRAN SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ARROWHEAD
- **Manufacturer:** Arrowhead Pharmaceuticals, Inc.
- **First approval:** 2025-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219947)
---
*AI Analytics · CC0 1.0*